Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more
Horizon Lines: A Quarterly Review of NDAs – January-March, 2026
The NDAs approved during the first quarter of 2026 have been divided into the dosage forms Injection, Tablets, Capsules, Oral solution, Gas, and other. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Hovione Names Chairman Stefan Doboczky as CEO
Tuesday, September 08, 2026
Hovione Holding AG has appointed Stefan Doboczky as chief executive officer, effective April 1, 2027, moving the company’s current board chairman into... read more
AtomVie Opens $160M Radiopharmaceutical CDMO Facility in Hamilton
Tuesday, September 08, 2026
AtomVie Global Radiopharma has opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, following an investment of more than $160... read more
Charles River Automates Endosafe Cartridge Production
Tuesday, September 08, 2026
Charles River Laboratories has brought a fully automated production suite for Endosafe bacterial endotoxin testing cartridges into full operation, ... read more
Onyx Scientific Invests $2 Million in UK API Manufacturing Expansion
Tuesday, September 08, 2026
Onyx Scientific will invest more than £1.5 million, or about $2 million, to expand commercial active pharmaceutical ingredient manufacturing capacity ... read more
Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed ... read more